A detailed history of Virtu Financial LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 74,354 shares of GTHX stock, worth $531,631. This represents 0.01% of its overall portfolio holdings.

Number of Shares
74,354
Holding current value
$531,631
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.2 - $4.98 $163,578 - $370,282
74,354 New
74,354 $170,000
Q4 2023

Feb 26, 2024

BUY
$1.12 - $3.73 $50,093 - $166,827
44,726 New
44,726 $136,000
Q3 2022

Nov 07, 2022

BUY
$5.17 - $16.99 $128,433 - $422,065
24,842 Added 246.42%
34,923 $436,000
Q2 2022

Aug 09, 2022

BUY
$4.04 - $8.51 $9,219 - $19,419
2,282 Added 29.26%
10,081 $50,000
Q1 2018

May 14, 2018

BUY
$19.05 - $41.76 $148,570 - $325,686
7,799 New
7,799 $289,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.